Nonmelanoma vs. Melanoma Skin Cancer: Key Differences in Origin, Behavior, and Management

Skin cancers are broadly categorized by cell of origin. Nonmelanoma skin cancers (NMSC) (basal cell carcinoma, squamous cell carcinoma) arise from keratinocytes. Melanoma arises from melanocytes. This fundamental difference drives behavior and management.

Cell of Origin & Epidemiology

Feature	Basal Cell Carcinoma (BCC)	Squamous Cell Carcinoma (SCC)	Melanoma
Origin	Basal keratinocytes	Squamous keratinocytes	Melanocytes (neural crest)
Incidence (US/yr)	~3.6 million	~1.8 million	~100,000 invasive
Metastasis Rate	<0.1%	2–5% (higher in high-risk)	~10–15% (thickness-dependent)
Mortality	Very low	~15,000/yr	~7,500/yr

Clinical Presentation

• BCC: Pearly papule/nodule, telangiectasia, rolled borders, ulceration ("rodent ulcer"). Slow-growing, locally destructive.
• SCC: Scaly/crusty plaque, keratotic nodule, ulcer. Faster growth. Arises from actinic keratosis.
• Melanoma: ABCDE – Asymmetry, Border irregularity, Color variation, Diameter >6mm, Evolution. Nodular: EFG (Elevated, Firm, Growing). Amelanotic: pink/red.

Risk Factors

• UV radiation (cumulative for NMSC; intermittent intense for melanoma).
• Fair skin, freckles, nevi count, family history, immunosuppression.
• Genetic: PTCH1 (BCC), TP53 (SCC), CDKN2A, BRAF (melanoma).

Treatment

• NMSC: Surgical excision (Mohs for high-risk/face), electrodesiccation & curettage (low-risk BCC/SCC in situ), topical (5-FU, imiquimod), radiation, hedgehog inhibitors (advanced BCC).
• Melanoma: Wide local excision (margins by Breslow depth), sentinel lymph node biopsy (SLNB) ≥T1b, adjuvant immunotherapy/targeted therapy (Stage III/IV), radiation for nodal/oligometastatic.

Prognosis

• NMSC: Excellent if treated early. Local recurrence risk.
• Melanoma: Stage-dependent. Stage I: >95% 10-yr survival. Stage IV: ~30% 5-yr (improving with immunotherapy).

Prevention

• Broad-spectrum SPF 30+, sun-protective clothing, shade, avoid tanning beds.
• Regular skin self-exams; annual dermatologist for high-risk.

Early detection saves lives, especially for melanoma.